Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle
Abstract Hepatocellular Carcinoma (HCC) is a malignancy with high mortality rates and limited treatment options. This study aimed to unearth the repurposable potential of FDA-approved drugs against specific genetic targets governing the HCC pathological pathways. The transcriptomics microarray datas...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2025-02-01
|
| シリーズ: | Scientific Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1038/s41598-025-87676-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|